Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

194 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
A dose-ranging study of the effects of ethyl-eicosapentaenoate in patients with ongoing depression despite apparently adequate treatment with standard drugs.
Peet M, Horrobin DF. Peet M, et al. Arch Gen Psychiatry. 2002 Oct;59(10):913-9. doi: 10.1001/archpsyc.59.10.913. Arch Gen Psychiatry. 2002. PMID: 12365878 Clinical Trial.
Comparison of therapeutic effects of omega-3 fatty acid eicosapentaenoic acid and fluoxetine, separately and in combination, in major depressive disorder.
Jazayeri S, Tehrani-Doost M, Keshavarz SA, Hosseini M, Djazayery A, Amini H, Jalali M, Peet M. Jazayeri S, et al. Among authors: peet m. Aust N Z J Psychiatry. 2008 Mar;42(3):192-8. doi: 10.1080/00048670701827275. Aust N Z J Psychiatry. 2008. PMID: 18247193 Clinical Trial.
Omega-3 polyunsaturated fatty acids in the treatment of schizophrenia.
Peet M. Peet M. Isr J Psychiatry Relat Sci. 2008;45(1):19-25. Isr J Psychiatry Relat Sci. 2008. PMID: 18587166 Review.
Omega-3 fatty acids in the treatment of psychiatric disorders.
Peet M, Stokes C. Peet M, et al. Drugs. 2005;65(8):1051-9. doi: 10.2165/00003495-200565080-00002. Drugs. 2005. PMID: 15907142 Review.
International variations in the outcome of schizophrenia and the prevalence of depression in relation to national dietary practices: an ecological analysis.
Peet M. Peet M. Br J Psychiatry. 2004 May;184:404-8. doi: 10.1192/bjp.184.5.404. Br J Psychiatry. 2004. PMID: 15123503
Eicosapentaenoic acid in the treatment of schizophrenia and depression: rationale and preliminary double-blind clinical trial results.
Peet M. Peet M. Prostaglandins Leukot Essent Fatty Acids. 2003 Dec;69(6):477-85. doi: 10.1016/j.plefa.2003.08.020. Prostaglandins Leukot Essent Fatty Acids. 2003. PMID: 14623502
A dose-ranging exploratory study of the effects of ethyl-eicosapentaenoate in patients with persistent schizophrenic symptoms.
Peet M, Horrobin DF; E-E Multicentre Study Group. Peet M, et al. J Psychiatr Res. 2002 Jan-Feb;36(1):7-18. doi: 10.1016/s0022-3956(01)00048-6. J Psychiatr Res. 2002. PMID: 11755456 Clinical Trial.
Omega-3 polyunsaturated fatty acid levels in the diet and in red blood cell membranes of depressed patients.
Edwards R, Peet M, Shay J, Horrobin D. Edwards R, et al. Among authors: peet m. J Affect Disord. 1998 Mar;48(2-3):149-55. doi: 10.1016/s0165-0327(97)00166-3. J Affect Disord. 1998. PMID: 9543204
Two double-blind placebo-controlled pilot studies of eicosapentaenoic acid in the treatment of schizophrenia.
Peet M, Brind J, Ramchand CN, Shah S, Vankar GK. Peet M, et al. Schizophr Res. 2001 Apr 30;49(3):243-51. doi: 10.1016/s0920-9964(00)00083-9. Schizophr Res. 2001. PMID: 11356585 Clinical Trial.
Depletion of omega-3 fatty acid levels in red blood cell membranes of depressive patients.
Peet M, Murphy B, Shay J, Horrobin D. Peet M, et al. Biol Psychiatry. 1998 Mar 1;43(5):315-9. doi: 10.1016/s0006-3223(97)00206-0. Biol Psychiatry. 1998. PMID: 9513745 Clinical Trial.
194 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback